Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Perrigo Company PLC (NYSE:PRGO)

Delayed Data
As of Nov 27
 -0.14 / -0.09%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Perrigo Co. plc is a global healthcare supplier. It develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, and active pharmaceutical ingredients. The company operates its business through following segments: Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, Active Pharmaceutical Ingredients, Specialty Sciences and Other Businesses. The Consumer Healthcare segment is manufacturer of OTC pharmaceutical products. Major product categories include analgesics, cough or cold or allergy or sinus, gastrointestinal, smoking cessation and animal health; secondary product categories include feminine hygiene, diabetes care and dermatological care. The Nutritionals segment develops, manufactures, markets and distributes store brand infant and toddler formula products, infant and toddler foods, and vitamin, mineral and dietary supplement products to retailers, distributors and consumers primarily in the United States, Canada, Mexico and China. The Rx Business segment develops, manufactures and markets primarily generic extended topical and other prescription pharmaceuticals. The Active Pharmaceutical Ingredients segment is based on the manufacture and supply of API to pharmaceutical companies for use in their production of pharmaceutical products. The Other Businesses segment category comprised of Israel Pharmaceutical and Diagnostic Products. The Specialty Sciences segment is comprised of assets focused predominantly on the treatment of Multiple Sclerosis. The company root back is in 1887. Perrigo was formed as a part of merger between Perrigo Co. and Elan Corp. Plc as on December 18, 2013 and is headquartered in Dublin, Ireland.

Contact Information

Perrigo Co. Plc
Treasury Building
Dublin Dublin 00200
P:(531) 709-4002
Investor Relations:



Other institutional42.94%
Individual stakeholders4.19%
Mutual fund holders34.02%

Top Executives

Joseph C. PapaChairman & Chief Executive Officer
John T. HendricksonPresident
Judy L. BrownChief Financial Officer & Executive Vice President
Thomas FarringtonChief Information Officer & Senior Vice President
Jatin ShahChief Scientific Officer & Senior Vice President